An experimental treatment by Pfizer and Arvinas delayed progression of breast cancer by more than three months compared to ...

Regeneron shares fell nearly 13% before the bell on Friday after its experimental drug for patients with a type of lung ...

(Reuters) -Regeneron shares fell nearly 18% on Friday after its experimental drug for patients with a type of lung condition ...

Yahoo Finance host Brad Smith tracks today's top moving stocks and biggest market stories in this Market Minute, including ...

Like opioids, SBI-810 works on the nervous system to relieve pain. The experimental compound is designed to target a receptor ...

Some patients with a rare form of ALS benefited from an experimental therapy, with biomarker evidence of reduced injury to neurons and even limited functional recovery.

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

Set to enter larger trial across 5 countries, it works by permanently turning off gene that causes high bad cholesterol ...

When Columbia neurologist and scientist Neil Shneider speaks to his ALS patients who volunteer for experimental therapies, he ...

Joe Walsh is the first Alzheimer's patient to be treated with an experimental nasal spray designed to reduce inflammation in ...

Sanofi and Regeneron said that drug candidate Itepekimab didn’t meet primary endpoint in a phase three study, although a ...